These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20552939)

  • 21. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
    Winstock AR; Lea T; Sheridan J
    Addiction; 2010 Feb; 105(2):335-42. PubMed ID: 20078490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA; Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
    Pelton LE; Strutton D; Smith MC
    J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Lawrinson P; Roche A; Terao H; Le PP
    Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical care in community pharmacies: practice and research in Peru.
    Alvarez-Risco A; van Mil JW
    Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prescription changes in pharmacies].
    Mandt I; Horn AM; Granås AG
    Tidsskr Nor Laegeforen; 2006 Jun; 126(13):1754-5. PubMed ID: 16794671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Welty TE
    Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic substitution: additional challenge for adherence in hypertensive patients?
    Håkonsen H; Eilertsen M; Borge H; Toverud EL
    Curr Med Res Opin; 2009 Oct; 25(10):2515-21. PubMed ID: 19708764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice change in community pharmacy: quantification of facilitators.
    Roberts AS; Benrimoj SI; Chen TF; Williams KA; Aslani P
    Ann Pharmacother; 2008 Jun; 42(6):861-8. PubMed ID: 18477730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
    Andersson K; Bergström G; Petzold MG; Carlsten A
    Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance-based pharmacy payment models: the case for change.
    Jackson J; Urick B
    Aust Health Rev; 2019 Oct; 43(5):502-507. PubMed ID: 31505158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic medicine substitution: a cross-sectional survey of the perception of pharmacists in North-Central, Nigeria.
    Auta A; Bala ET; Shalkur D
    Med Princ Pract; 2014; 23(1):53-8. PubMed ID: 24217185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription, Dispensation, and Generic Medicine Replacement Ratios: Influence on Japanese Medicine Costs.
    Yokoi M; Tashiro T
    Glob J Health Sci; 2015 May; 8(1):29-35. PubMed ID: 26234979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists.
    Allenet B; Barry H
    Pharm World Sci; 2003 Oct; 25(5):197-202. PubMed ID: 14584225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.